SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-08-000059
Filing Date
2008-11-06
Accepted
2008-11-06 17:00:40
Documents
6
Period of Report
2008-09-27

Document Format Files

Seq Description Document Type Size
1 FORM 10Q edgar3rdqtr0810q115.htm 10-Q 552362
2 SEPARATION AGREEMENT exh101to3q2008martinoseparat.htm EX-10.1 46139
3 CERTIFICATION exhibit31ceocert.htm EX-31.1 6912
4 CERTIFICATION exhibit31cfocert.htm EX-31.2 6825
5 CERTIFICATION exhibit32ceo.htm EX-32.1 3159
6 CERTIFICATION exhibit32cfo.htm EX-32.2 3318
  Complete submission text file 0000878088-08-000059.txt   620231
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 081167863
SIC: 2834 Pharmaceutical Preparations